# Bicalutamide With or Without Enzastaurin in Treating Patients With Prostate Cancer

> **NCT00685633** · PHASE2 · WITHDRAWN · sponsor: **Eastern Cooperative Oncology Group**

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** bicalutamide
- **DRUG:** enzastaurin hydrochloride

## Key facts

- **NCT ID:** NCT00685633
- **Lead sponsor:** Eastern Cooperative Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2008-12
- **Primary completion:** 2010-06
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2013-08-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00685633

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00685633, "Bicalutamide With or Without Enzastaurin in Treating Patients With Prostate Cancer". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT00685633. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*